AISNMA welcomes the decision
The All India Syringe & Needle Manufacturers Association (AISNMA), the nodal body for domestic syringe manufacturers welcomes the strategic move by the government clarifying the notification issued recently that it is not an export ban on any kind/type of Syringes and is only a quantitative restriction on the export of certain type of specified syringes, for a limited duration of three months only.
The three categories are 0.5 ml/ 1ml AD (auto–disable) syringes, 0.5 ml/1 ml/2 ml/3 ml disposable syringes and 1ml/2 ml/3 ml RUP (re-use prevention) syringes.
“So the syringes that are not used for covid vaccination like insulin syringes, 0.3 ML, 5 ML and larger sizes of 10 ML, 20 ML & 50 ML etc will be allowed to be exported. This is going to be a relief for India’s international buyers and will majorly help to maintain India’s reputation as a credible global supplier and our relationship built over the years with them, said Rajiv Nath, President, AISNMA – the All India Syringes & Needles Manufacturers Association.
“We are grateful to the government for listening to the request of the domestic syringe and needle manufacturers to lift the export restriction on non-covid sizes of syringes which can’t be used in India for vaccination and will be a wasted capacity otherwise and it will put the domestic syringe makers in an awkward situation,” expressed Nath.
AISNMA members also hope that the Syringes used for Children vaccination/immunization programmes may be continued to be allowed for exports as requested by UN Organizations to our Members and the Government of India under the monthly quantitative restrictions as India cannot deprive those children of those immunisation commitments.
“While the supply chain is currently challenged due to peak season demand for dengue and typhoid which are the priority needs as we can’t afford any shortages in the country in curative healthcare delivery we hope that the market demand will ease in November beginning/middle, as is usually the case every year and then our Members will be augmented further supplies for the vaccination program so that India can go back to their pre-covid lives as before,” said Vimal Khemka, General Secretary, AiSNMA.
“We again request The Union government to place orders for AD syringes with the manufacturers in India well in advance so that the latter could ramp up supplies. Clarity should be given of India’s quarterly needs by MoH&FW for the calendar year 2022 as we can’t plan on a two to four months window horizon basis. To ramp up capacity, we need an order confirmation at least nine months to a year in advance,” Nath.